{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T22:45:45Z","timestamp":1762641945142},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T00:00:00Z","timestamp":1488758400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl. Stroke Res."],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s12975-017-0527-5","type":"journal-article","created":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T14:56:27Z","timestamp":1488812187000},"page":"341-346","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Re-evaluate the Efficacy and Safety of Human Urinary Kallidinogenase (RESK): Protocol for an Open-Label, Single-Arm, Multicenter Phase IV Trial for the Treatment of Acute Ischemic Stroke in Chinese Patients"],"prefix":"10.1007","volume":"8","author":[{"name":"On behalf of the RESK investigators","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiazhi","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xihua","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liying","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,6]]},"reference":[{"key":"527_CR1","doi-asserted-by":"crossref","unstructured":"Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S. Heart disease and stroke statistics\u20142014 update. Circulation. 2014;129","DOI":"10.1161\/01.cir.0000442015.53336.12"},{"key":"527_CR2","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/STR.0b013e318284056a","volume":"44","author":"EC Jauch","year":"2013","unstructured":"Jauch EC, Saver JL, Adams HP, Bruno A, Demaerschalk BM, Khatri P, McMullan PW, Qureshi AI, Rosenfield K, Scott PA. Guidelines for the early management of patients with acute ischemic stroke a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2013;44:870\u2013947.","journal-title":"Stroke"},{"key":"527_CR3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2710.2011.01329.x","volume":"37","author":"A Eissa","year":"2012","unstructured":"Eissa A, Krass I, Bajorek B. Barriers to the utilization of thrombolysis for acute ischaemic stroke. J Clin Pharm Ther. 2012;37:399\u2013409.","journal-title":"J Clin Pharm Ther"},{"key":"527_CR4","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1161\/STROKEAHA.110.604249","volume":"42","author":"Y Wang","year":"2011","unstructured":"Wang Y, Liao X, Zhao X, Wang DZ, Wang C, Nguyen-Huynh MN, Zhou Y, Liu L, Wang X, Liu G, Li H. Using recombinant tissue plasminogen activator to treat acute ischemic stroke in China: analysis of the results from the Chinese National Stroke Registry (CNSR). Stroke. 2011;42:1658\u201364.","journal-title":"Stroke"},{"key":"527_CR5","first-page":"5595","volume":"9","author":"L Zhao","year":"2015","unstructured":"Zhao L, Zhao Y, Wan Q, Zhang H. Urinary kallidinogenase for the treatment of cerebral arterial stenosis. Drug Des Devel Ther. 2015;9:5595\u2013600.","journal-title":"Drug Des Devel Ther"},{"key":"527_CR6","first-page":"306","volume":"40","author":"D Ding","year":"2007","unstructured":"Ding D, Lv C, Ding M, Su B, Chen F. A multicenter, randomized, double-blinded and placebo-controlled study of acute brain infarction treated by human urinary kallidinogenase. Chin J Neurol. 2007;40:306\u201310.","journal-title":"Chin J Neurol"},{"key":"527_CR7","first-page":"246","volume":"48","author":"Chinese Society of Neurology, Cerebrovascular Disease Group of the Chinese Society of Neurology","year":"2015","unstructured":"Chinese Society of Neurology, Cerebrovascular Disease Group of the Chinese Society of Neurology. Chinese guidelines of diagnosis and treatment for acute ischemic stroke (2014). Chin J Neurol. 2015;48:246\u201357.","journal-title":"Chin J Neurol"},{"key":"527_CR8","first-page":"570","volume":"12","author":"C Zhang","year":"2012","unstructured":"Zhang C, Tao W, Liu M, Wang D. Efficacy and safety of human urinary kallidinogenase injection for acute ischemic stroke: a systematic review. Chin J Evid-based Med. 2012;12:570\u20136.","journal-title":"Chin J Evid-based Med"},{"key":"527_CR9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0140-6736(74)91639-0","volume":"2","author":"G Teasdale","year":"1974","unstructured":"Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974;2:81\u20134.","journal-title":"Lancet"},{"key":"527_CR10","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1161\/01.STR.20.7.864","volume":"20","author":"T Brott","year":"1989","unstructured":"Brott T, Adams Jr HP, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20:864\u201370.","journal-title":"Stroke"},{"key":"527_CR11","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/003693305700200504","volume":"2","author":"J Rankin","year":"1957","unstructured":"Rankin J. Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J. 1957;2:200\u201315.","journal-title":"Scott Med J"},{"key":"527_CR12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.0b013e318245d2a9","volume":"78","author":"D Strbian","year":"2012","unstructured":"Strbian D, Meretoja A, Ahlhelm F, Pitk\u00e4niemi J, Lyrer P, Kaste M, Engelter S, Tatlisumak T. Predicting outcome of IV thrombolysis-treated ischemic stroke patients the DRAGON score. Neurology. 2012;78:427\u201332.","journal-title":"Neurology"}],"container-title":["Translational Stroke Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12975-017-0527-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-017-0527-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-017-0527-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T06:21:51Z","timestamp":1568874111000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12975-017-0527-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,6]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["527"],"URL":"https:\/\/doi.org\/10.1007\/s12975-017-0527-5","relation":{},"ISSN":["1868-4483","1868-601X"],"issn-type":[{"type":"print","value":"1868-4483"},{"type":"electronic","value":"1868-601X"}],"subject":[],"published":{"date-parts":[[2017,3,6]]}}}